Alzheon, Inc., a clinical-stage biopharmaceutical company developing investigational therapies and diagnostic assays for ...
Phase 3 and Phase 2 Studies in APOE4/4 Alzheimer's Patients Show Favorable Safety, Low Risk for Brain Bleed and Edema (ARIA), and Neurovascular Protection. Long-Term Phase 3 and P ...
Tracking microstructural shifts in nerve tracts The research team identified these anatomical modifications using diffusion ...
In this fourth and final episode, the panel looks ahead to the future of brain tumor imaging, discussing how quantitative ...
Remepy, a pioneer in Hybrid Drugstm, today announced the publication of new mechanistic findings in npj Parkinson's Disease (Nature Portfolio). The study provides insight, for the first time, into how ...
A court hearing held Thursday in the case of a Logan man, who’s charged with having opened fire on law enforcement officers ...
The cerebellum, historically linked only to motor control, is now recognized as a vital hub for executive function, emotion, and social cognition. Through ...
Eli Lilly and Company (NYSE: LLY) today announced it will present 16 abstracts at the 2026 Alzheimer's Association ...
ME/CFS brain fog is measurable on an MRI - new research links impaired glymphatic waste clearance to sleep disruption and ...